Biomedical subjects

Y Sanjo

Publications and source records attributed to Y Sanjo.

14 recordsLinked to original sources

PubMed2006

Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, does not alter the electroencephalographic effect of isoflurane in swine model.

BACKGROUND: beta-Adrenergic blocking agents may interact with anaesthetics, and several studies suggest that beta-blockers attenuate electroencephalographic responses during general anaesthesia. We have investigated the influence of landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, on the electroencephalographic effect of isoflurane in pigs. METHODS: Ten swine were anaesthetized through inhalation of 2% isoflurane. The inhalational concentration was then decreased to 0.5% and maintained for 25 min, before being returned to 2% and maintained for a further 25 min (control period). After control measurements, infusion of landiolol (at 0.125 mg kg(-1) min(-1) for 1 min, and then at 0.04 mg kg(-1) min(-1)) was started. After a 20 min stabilization period, the inhalational concentration was varied as in the control period (40 gamma landiolol). Finally, infusion of landiolol was increased from 0.04 to 0.2 mg kg(-1) min(-1), and after a 20 min stabilization period, the inhalational concentration was again varied as in the control period (200 gamma landiolol). End-tidal isoflurane concentrations and spectral edge frequencies were recorded throughout the study. Analysis of the pharmacodynamics was performed using a sigmoidal inhibitory maximal effect model for spectral edge frequency vs effect-site concentration. RESULTS: There were no significant differences in the effect of isoflurane among the conditions used. Landiolol did not shift the concentration-effect relationship [the effect-site concentration that produced 50% of the maximal effect was 1.35 (0.17)% under control conditions, 1.30 (0.12)% at 40 gamma landiolol, and 1.38 (0.30)% at 200 gamma landiolol]. CONCLUSION: Landiolol does not alter the electroencephalographic effect of isoflurane.

Adrenergic beta-1 Receptor Antagonists↗

PubMed2000

Evaluation of the PhysioFlex closed-circuit anaesthesia machine.

The concentrations of nitrous oxide, sevoflurane and oxygen in the circle system of a closed-circuit anaesthesia machine, the PhysioFlex, were measured in seven patients. During anaesthesia, the settings for each gas were changed and their concentrations recorded. At the induction of anaesthesia, it took 80-510s (median 190s) for the end-tidal sevoflurane concentration to reach 2.0%, and 920-2640s (median 1500s) for the oxygen in the breathing circuit to reach 30%. At this time, the nitrous oxide concentration was 60+/-3% (mean+/-SD). During anaesthesia, it took 90-480s (median 140s) for the end-tidal sevoflurane concentration setting to decrease from 3.0 to 1.0%, and 90-400s (median 110s) to return from 1.0 to 3.0%. When the inspired oxygen was increased from 30 to 50%, circuit concentrations reached equilibrium in 40-60s (median 40s), and when decreased from 50% back to 30%, equilibrium took 310-470s (median 450s). During recovery from anaesthesia, inspiratory sevoflurane concentration took 40-70s (median 50s) to decrease to 0.2%. The PhysioFlex provided adequate control of sevoflurane and oxygen concentrations, but not of increasing nitrous oxide concentrations.

Adult↗

PubMed2000

Comparison of compound A concentrations with sevoflurane anaesthesia using a closed system with a PhysioFlex anaesthesia machine vs a low-flow system with a conventional anaesthesia machine.

Sevoflurane anaesthesia was conducted using a totally closed circuit PhysioFlex anaesthesia machine (PhysioFlex group) or with a standard Modulus CD anaesthesia machine (Modulus group) (n = 8 in each group). The PhysioFlex was used under closed system conditions and the Modulus was used under low-flow system conditions (flow rate 1 litre min-1). Concentrations of sevoflurane degradation products and the temperature of soda lime were compared. Degradation products in the circuit were measured hourly, and the temperature of soda lime was monitored. The only degradation product detected was CF2 = C(CF3)-O-CH2F (compound A). Maximum concentrations of compound A were significantly lower (median 8.5 (range 5.4-15.9) ppm) in the PhysioFlex than in the Modulus group (21.2 (16.5-27.4) ppm) (P < 0.05). The maximum temperature of soda lime was also significantly lower in the PhysioFlex group (35.3 (32.1-36.3) degrees C vs 44.6 (43.0-47.1) degrees C, respectively) (P < 0.05). Hourly compound A concentrations were lower in the PhysioFlex group than in the Modulus group. End-tidal sevoflurane concentrations during measurement of degradation products were not different between groups. Therefore, use of the totally closed PhysioFlex system may significantly reduce compound A concentrations compared with low-flow anaesthesia using a standard anaesthesia machine.

Adult↗

PubMed1999

Ergonomic automated anesthesia recordkeeper using a mobile touch screen with voice navigtion.

OBJECTIVE: To develop an ergonomically designed computerized recordkeeping tool for anesthesiologists that allows the clinician to maintain visual contact with the patient while performing recordkeeping. METHODS: To simplify the human interface software, we developed two general use software components. All purpose menu type 1 (APM1) was used for entering events using a tree structured menu. APM1 was designed to adapt to the limits of human memory, by using Miller's rule of 7 to guide the input process. APM1 can be considered to be a three-dimensional table list consisting of 7 vertical and 7 horizontal choices, which has further 5 tree-structured divergences. APM1 is also completely configurable by the user. All purpose menu 2 (APM2) was used to implement the system-initiated human interface where the system will prompt the user by voice for each entry. When users touch a key on APM1 and APM2, the system was designed to respond with a voice prompt. A touch-screen was also utilized and designed to fit the anesthesia machine. The screen is equipped with a small speaker for voice response and a microphone for voice recognition. The positions of the screen are adjustable supported by a long flexible limb (85 cm). RESULTS: After improving the design, systems were assembled for 10 operating rooms. Of the multiple features of the VOCAAR user interface, the following were well accepted by users and employed daily: touch-screen input, and voice response. The noncompulsory use rate was 87% during the initial 2 weeks, increased to 94% after 2 weeks and 100% after two months. The mean sound emission by voice response (n = 10, mean +/- SD) was 8.2 +/- 2.3 dB at the main anesthetist site (35 cm from the speaker mounted on the touch-screen), 2.2 +/- 1.3 dB at the staff site (1.5 m from the touch-screen), which was only audible for anesthesiologist but for surgeon. DISCUSSION: An EARK system was designed to allow the user to maintain visual contact with the patient while performing recordkeeping tasks. The combination of a mobile touch screen and voice response/recognition facilitated the design goals of the system. Although the system has enjoyed universal clinical acceptance, the voice functions remain too limited to satisfy the needs of a completely handsfree user interface. Enhancements to voice recognition technology will offer the potential for improved functionality. Additional research is also needed to better define the relationship between vigilance and visual contact with the patient.

Anesthesiology↗

PubMed1999

Predicted sevoflurane partial pressure in the brain with an uptake and distribution model comparison with the measured value in internal jugular vein blood.

OBJECTIVE: In order to predict the partial pressure of volatile anesthetics in brain tissue, we developed a pharmacokinetic simulation model suitable for real time application. The accuracy of this model was examined by comparing the predicted values against measured values for blood sampled from the internal jugular vein, which was used as a measure of the partial pressure in the brain. METHODS: Our model consists of six compartments: alveoli, arterial blood, a group of vessel-rich organs (VRG), muscle, fat, and venous blood. A volatile anesthetic, sevoflurane partial pressure in each compartment were calculated using the parameters of volume, blood flow, and solubility for each tissue as reported in previous studies. Simulated sevoflurane partial pressures in VRG were considered to reflect those in the brain. We studied 11 patients undergoing elective abdominal surgery or mastectomy. Sevoflurane was maintained at a concentration of 3% (by vaporizer setting) for 25 min. Sampling points were at 0 min (before sevoflurane administration) and 1, 2, 4, 9, 16, and 25 min after the start of inhalation. We measured the sevoflurane partial pressure in inspiratory gas (PI(S)), in end-expiratory gas (PET(S)), in arterial blood (Pa(S)), and in internal jugular vein blood (Pj(S)). These values were compared against those for the simulated brain (PB(S)sim). RESULTS: The sevoflurane partial pressures increased, in order from least rapid to most rapid, as follows: Pj(S), PB(S)sim, Pa(S), PET(S), and PI(S). The differences between Pj(S) and PB(S)sim were significantly smaller than those between Pj(S) and PET(S) at all sampling points. PB(S)sim did not differ significantly from Pj(S) at any sampling points after 4 min of inhalation, while PET(S) differed significantly from Pj(S) at all sampling points. CONCLUSION: We conclude that our model is clinically useful for predicting sevoflurane partial pressure in the brain, assuming that Pj(S) reflects the sevoflurane partial pressure in the brain.

Anesthetics, Inhalation↗

PubMed1998

Comparative carbon dioxide output through injured and noninjured peritoneum during laparoscopic procedures.

Tension pneumoperitoneum may force gas into a small injured vessel if the opening is kept patent by surrounding tissues. However, the amount of carbon dioxide (CO2) that penetrates through injured or noninjured peritoneum has not been systematically determined. In 25 patients undergoing elective laparoscopic ultrasonography and cholecystectomy, CO2 output (VCO2) and O2 uptake (VO2) were measured at baseline and during anesthesia, pneumoperitoneum, laparoscopic surgical procedure (Surgery), and after hemostasis of the surgical field (Postsurgery). Before anesthesia, VCO2/BSA and VO2/BSA were 97.7 +/- 11.3 and 116.0 +/- 10.0 ml x min(-1) x m(-2), respectively. During anesthesia, they fell to 72.3 +/- 6.0 and 89.8 +/- 7.6 ml x min(-1) x m(-2), respectively (p < 0.05). VCO2/BSA increased to 96.0 +/- 11.1 at pneumoperitoneum (p < 0.05) and increased further to 126.1 +/- 11.0 ml x min(-1) x m(-2) at Surgery. It fell to 111.7 +/- 10.9 ml x min(-1) x m(-2) Postsurgery. VO2/BSA remained unchanged during pneumoperitoneum. Minute volume increased from 2.24 +/- 0.20 in anesthesia to 2.89 +/- 0.25, 4.01 +/- 0.32, and 3.46 +/- 0.28 L x min(-1) x m(-2) during pneumoperitoneum, Surgery, and Postsurgery, respectively, to maintain PaCO2. We conclude that the amount of CO2 absorbed following pneumoperitoneum prior to surgery is lower than that during Surgery or Postsurgery. The amount of CO2 absorbed through the surgical field was 2.3 times higher than that through the nonsurgical field while that from the peritoneum after hemostasis of surgical field was 1.6 times higher.

Absorption↗

PubMed1998

Awakening propofol concentration with and without blood-effect site equilibration after short-term and long-term administration of propofol and fentanyl anesthesia.

BACKGROUND: The propofol awakening concentration can vary. However, the effect site awakening propofol concentration will be a fixed value. The purpose of this study was to determine the awakening propofol concentrations obtained from infusion Schede using abrupt discontinuation of propofol (half-maximal effective concentration [EC50]) or a descending decrease in concentration to allow blood-effect site equilibration (EC50eq). METHODS: Patients undergoing short-term (group 1) and long-term (group 2) elective surgery were anesthetized with computer-assisted continuous infusion of propofol and fentanyl, with both groups receiving the same propofol (3 microg/ml) and fentanyl (1 ng/ml) concentrations 20-30 min before the end of surgery until the end. Then both groups were further divided into two subgroups: subgroup A abrupt discontinuation, and subgroup B descending concentrations of propofol (15-min duration per concentration). In the A subgroups, the response to verbal command was evaluated every 30 s. In the B subgroups, the blood propofol concentrations just permitting and just preventing response to command were averaged individually. The EC50 and EC50eq values were determined by probit analysis. RESULTS: The EC50 of group 1A was 1 microg/ml, which was significantly less than the 1.6 microg/ml of group 2A (P < 0.05). The awakening time of group 1A was 5.2 +/- 1.8 min, which was significantly shorter than the 9.3 +/- 3.5 min of group 2A (means +/- SD). The EC50eq of both groups 1B and 2B was 2.2 microg/ml. CONCLUSIONS: The EC50eq was independent of propofol infusion length, compared with the EC50. Thus the potential for hysteresis during emergence from propofol anesthesia was confirmed.

Adult↗

PubMed1997

Pure silicate fragment in a recurrent stone former of calcium oxalate.

Long-time oral intake of magnesium-silicate-containing drugs is thought to be a causative factor inducing silicate urolithiasis. Besides, magnesium seems to play an anti-urolithogenic part in the formation of calcium oxalate stones. We report a recurrent calcium oxalate former who had been treated with magnesium aluminometasilicate antacid for gastric ulcer for approximately 17 years. One of the fragments found during extracorporeal shock wave lithotripsy was identified as 100% silicate. Deposition of silica was also found on other fragments. A large dose of magnesium (given in a part of the drug) might have little influence on the formation of calcium oxalate.

Aluminum Compounds↗

PubMed1987

A small bypass mixing chamber for monitoring metabolic rate and anesthetic uptake: the bymixer.

We developed a miniature mixing chamber, the bymixer, that aids in the measurement of respiratory gas metabolism and inhalation anesthetic uptake. A small fraction of total respiratory gas flow is bypassed from the inspiratory or expiratory limb of the breathing circuit to the bymixer. We tested the relationship between total flow and bypass flow. To analyze the error and response time of the system, we compared the mixed expired carbon dioxide from the bymixer (capacity, 0.3 L, ratio of bypass flow to total flow, 1/4.5) with that from a conventional 2.0-L mixing chamber in 15 volunteers and 12 anesthetized patients during spontaneous or controlled ventilation. Bypass flow correlated well with total flow (r2 = 0.999 to 1.000) when total flow ranged from 0 to 70 L/min and the ratio of bypass flow to total flow ranged from 1/3 to 1/20. The difference between the values of mixed expired carbon dioxide from the two mixing chambers was small, ranging from -0.03 to 0.01 vol% in both of the ventilatory modes. The relative error was within 2.3% of the carbon dioxide values obtained from the conventional chamber. We observed the error at the lowest minute volume (4 L/min). The 90% response time of the bymixer (24.8 seconds) was similar to that of the conventional chamber (19.1 seconds) at a minute volume of 7.5 L/min. For clinical use, we combined a conventional breathing circuit with two bymixers, one for mixing inspired gas and the other for mixing expired gas. We found this device accurate and easy to use.

Anesthesia, General↗

PubMed1985